Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation

Overview of attention for article published in JAMA Network Open, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 147,339 followers.

👀New study from colleagues in the Health Outcomes Research Group @MSKCancerCenter validates Medicare claims-based approach to studying ⚖️ clinical trial enrollment, 📰 in @JAMANetworkOpen: https://t.co/KYYMVi3N0s @ebludmir @DrLisaDiamond @Rrkotecha @Tri…

RT @DrOlaLandgren: This cohort study finds National Clinical Trial (NCT) identifiers on Medicare claims for care in cancer clinical trials.…

This cohort study finds National Clinical Trial (NCT) identifiers on Medicare claims for care in cancer clinical trials. ⁦@peterbachmd⁩ ⁦@JAMANetworkOpen⁩ ⁦@MSKCancerCenter⁩ https://t.co/m3LaArCOBa

New article: Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation https://t.co/p5aUn04zES #MMSM #MultipleMyeloma #hematology https://t.co/yjnemKDR9m

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.